Traditional Chinese medicine composition for inhibiting growth of hysteromyoma

CN119679809AInactive Publication Date: 2025-03-25MOM LIFE STATION CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411793599.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-12-06
Publication Date
2025-03-25
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure CN119679809A_ABST
    Figure CN119679809A_ABST
Patent Text Reader

Abstract

The invention discloses a traditional Chinese medicine composition for inhibiting growth of hysteromyoma, and relates to the technical field of traditional Chinese medicine compositions. The traditional Chinese medicine composition comprises the following raw material components in parts by weight: 10-30 parts of pachymic acid, 10-30 parts of paeonol, 10-30 parts of paeoniflorin, 10-30 parts of berberine and 10-30 parts of kaempferol. According to the traditional Chinese medicine composition for inhibiting growth of hysteromyoma, through product application of pachymic acid, paeonol, paeoniflorin, berberine or kaempferol in the aspect of hysteromyoma, the composition can be applied to beauty products or pharmaceutical preparations, the purpose of preventing, inhibiting or treating hysteromyoma is achieved, two groups of traditional Chinese medicine compositions are proportioned and dissolved, and the traditional Chinese medicine composition for inhibiting growth of hysteromyoma is obtained. The traditional Chinese medicine composition has the advantages that the traditional Chinese medicine composition with the optimal ratio is selected by using a cleaning solution which is prepared by adding a DMEM (dulbecco's modified eagle medium) high-glucose culture medium and dissolving to prepare solutions with different concentrations and filtering and sterilizing the cleaning solution by using a 0.22 mu m microporous filter membrane, so that the safety of HUSMC (human uterine smooth muscle cells) is subjected to experimental comparison, and the effect of inhibiting or treating hysteromyoma is improved by selecting the traditional Chinese medicine composition with the optimal ratio.
Need to check novelty before this filing date? Find Prior Art